Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study.
Thompson W, Yu B, Porter J, Fang J, Ferreira-Legere LE, Austin PC, Jackevicius CA, Ross H, Lee DS, Weisman A, Farkouh ME, Gershon AS, Atzema CL, Kwong JC, Ha A, Džavík V, Udell JA.
Thompson W, et al. Among authors: porter j.
BMJ Open Diabetes Res Care. 2025 Aug 7;13(4):e004677. doi: 10.1136/bmjdrc-2024-004677.
BMJ Open Diabetes Res Care. 2025.
PMID: 40780839
Free PMC article.